Fetal Monitoring Market

Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global fetal monitoring market was valued at US$ 3.7 billion in 2021 and is expected to register a revenue CAGR of 7% to reach US$ 6.80 billion by 2030.

Market Fundamentals 

Fetal monitoring devices track maternal contractions, heart rate, and movement of the fetus and assist in identifying general malfunctions and abnormalities in the fetus. Fetal monitoring is essential in medical practice to continuously monitor the unborn child's health and guarantee a safe delivery. The baby's heart rate and other movements are measured during fetal monitoring. Fetal monitoring is carried out during late pregnancy and labour since it is essential for both the mother and the baby to be safe and healthy. These are also used to keep a look at jaundice, chronic mental retardation, lung and newborn illnesses, hypothermia, and other medical conditions. Electronic fetal monitors or handheld dopplers are typically used for fetal monitoring. To prevent difficulties during delivery, whether the patient receives an epidural, or if oxytocin is required to initiate or speed up labor, fetal monitoring is essential.

[123454546]

Market Dynamics

The global fetal monitoring market is expected to register significant revenue growth as a result of rising preterm births, growing awareness of preventive care and prenatal health management, and active governmental and non-governmental initiatives. On the other hand, untapped emerging markets and wireless and portable devices are expected to present profitable opportunities in the future. However, the strict regulatory requirements, the high cost of fetal monitoring systems, and the prevalence of dropping birth rates are expected to hamper market revenue growth to some extent.

Market Ecosystem

The global fetal monitoring market is analyzed from six perspectives: product, portability, method, application, end user, and region.

Fetal Monitoring Market by Product

[13243546]

Based on product, the global fetal monitoring market is segmented into ultrasound, fetal electrodes, telemetry devices, electronic fetal monitoring, accessories & consumables, and others. 

Ultrasound is sub-segmented into 2D, 3D, 4D, and doppler imaging whereas electronic fetal monitoring is sub-segmented into external and internal. 

The ultrasound segment dominates the global fetal monitoring devices market owing to technology improvements, increased congenital malformations, maternal mortality, and increasing regulatory approvals.  

Fetal Monitoring Market by Portability

Based on portability, the global fetal monitoring market is segmented into portable and non-portable systems. 

The non-portable systems account for the majority of the market revenue share due to their widespread use in hospitals and diagnostic facilities to evaluate fetal and maternal health.

Fetal Monitoring Market by Method

Based on the method, the global fetal monitoring market is segmented into invasive and non-invasive systems. 

The non-invasive devices segment accounts for the majority of the market revenue share. Particularly in high-risk pregnancies, non-invasive technologies are widely acknowledged for their safer way of identifying and monitoring the fetus. The revenue growth of this segment is driven by the increasing approvals of various non-invasive monitoring devices and emerging advanced technologies.

Fetal Monitoring Market by Application

Based on application, the global fetal monitoring market is segmented into intrapartum fetal monitoring and antepartum fetal monitoring. 

The antepartum fetal monitoring segment accounts for the largest revenue share in the market. Throughout the entire gestation period, antepartum fetal monitoring is done to identify any congenital fetal anomalies. The antepartum segment is expanding due to intensive monitoring protocols, recent product introductions, an increasing occurrence of fetal abnormalities, and mother fatalities.

Fetal Monitoring Market by End User

Based on end user, the global fetal monitoring market is segmented into hospitals, obstetrics & gynecology clinics, and home settings. 

The hospital segment dominates the global market during the forecast period. The revenue growth of this segment can be attributed to a variety of factors, including the expansion of hospital technology and the rise in the frequency of pregnancy operations. Government funding and technological improvements are stimulating the installation of new equipment in hospitals fostering market revenue growth.

Fetal Monitoring Market by Region

Based on region, the global fetal monitoring market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). 

North America accounts for about two-fifths of the revenue share of the global fetal monitoring market, which is the largest regional share. This is credited to the province's sophisticated healthcare infrastructure, swift adoption of cutting-edge technologies, and well-funded healthcare programs. 

The Asia Pacific region will register the highest revenue CAGR during the forecast period. The market is expanding in this area due to rising firm investments in the development of fetal monitors as well as rising activities by governmental and non-governmental organizations to improve maternal/fetal health globally.

Competitive Landscape

The key players operating the market global fetal monitoring market include:    

• Koninklijke Philips N.V. 
• Cardinal Health, Inc.
• Monarch Meditech 
• GE Healthcare 
• Siemens Healthineers 
• Trivitron Healthcare 
• Shenzhen Comen Medical Instruments Co., Ltd.
• FUJIFILM SonoSite, Inc. 
• Life Plus Natus Medical Incorporated
• Huntleigh Healthcare Limited
• The Cooper Companies Inc. 
• Dott Medical Co. Ltd.
• CONTEC Medical Systems Co., Ltd. 
• EDAN Diagnostics, Inc.

Strategic Developments

• In February 2022, to increase its portfolio of ob-gyn and fertility medical devices, CooperSurgical announced to purchase of Cook Medical's reproductive health division.
• In June 2021, the remote pregnancy monitoring business Nuvo Group announced that their INVU system has received FDA supplementary 510(k) permission to add a new uterine activity module. INVU is a wearable progeny monitoring device that is prescribed by a doctor.
• In June 2020, during the COVID-19 conference, Royal Phillips announced the expansion of its remote patient monitoring technology for at-risk populations. To minimize the spread of the coronavirus, Phillips introduced the Avalon CL fetal and maternal pod and patch, which reduces needless physical contact between healthcare professionals and patients.
• In July 2019, Braunschweig Municipal Hospital and Siemens Healthineers collaborated to offer patients high-quality, affordable medical treatment. The hospital will be able to confidently plan its expenses with the help of a financing plan. Siemens Healthineers will supply about 140 new devices as part of this technical cooperation and make sure the fleet of devices continues to represent the state-of-the-art. 

Frequently Asked Questions About This Report